These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17546253)

  • 1. Cross-reactivity of new insulin analogs in insulin assays.
    Vieira JG; Tachibana TT; Ferrer CM; Reis AF
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):504-5. PubMed ID: 17546253
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactivity of Actrapid and three insulin analogues in the Abbott IMx insulin immunoassay.
    Song D; Davidson J
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):197-8. PubMed ID: 17362590
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reactivity of insulin analogs with the Diasorin Liaison insulin assay.
    Gruson D; Maisin D; Preumont V; Vandeleene B
    Clin Chem Lab Med; 2011 Jun; 49(6):1081-2. PubMed ID: 21410416
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay.
    Moriyama M; Hayashi N; Ohyabu C; Mukai M; Kawano S; Kumagai S
    Clin Chem; 2006 Jul; 52(7):1423-6. PubMed ID: 16690737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.
    Heurtault B; Reix N; Meyer N; Gasser F; Wendling MJ; Ratomponirina C; Jeandidier N; Sapin R; Agin A
    Clin Chem Lab Med; 2014 Mar; 52(3):355-62. PubMed ID: 24150210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays.
    Owen WE; Roberts WL
    Clin Chem; 2004 Jan; 50(1):257-9. PubMed ID: 14709671
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-reactivity of 12 recombinant insulin preparations in the Beckman Unicel DxI 800 insulin assay.
    Glenn C; Armston A
    Ann Clin Biochem; 2010 May; 47(Pt 3):264-6. PubMed ID: 20392753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of insulin analogues with three insulin assays.
    Dayaldasani A; Rodríguez Espinosa M; Ocón Sánchez P; Pérez Valero V
    Ann Clin Biochem; 2015 May; 52(Pt 3):312-8. PubMed ID: 25172526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elecsys insulin assay: free insulin determination and the absence of cross-reactivity with insulin lispro.
    Sapin R; Le Galudec V; Gasser F; Pinget M; Grucker D
    Clin Chem; 2001 Mar; 47(3):602-5. PubMed ID: 11238323
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin analogues as a new example of interference in insulin assays.
    Ismail AA
    Ann Clin Biochem; 2016 Jan; 53(Pt 1):181-2. PubMed ID: 26063167
    [No Abstract]   [Full Text] [Related]  

  • 11. Top-down mass spectrometric immunoassay for human insulin and its therapeutic analogs.
    Nedelkov D; Niederkofler EE; Oran PE; Peterman S; Nelson RW
    J Proteomics; 2018 Mar; 175():27-33. PubMed ID: 28780057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM).
    Peterman S; Niederkofler EE; Phillips DA; Krastins B; Kiernan UA; Tubbs KA; Nedelkov D; Prakash A; Vogelsang MS; Schoeder T; Couchman L; Taylor DR; Moniz CF; Vadali G; Byram G; Lopez MF
    Proteomics; 2014 Jun; 14(12):1445-56. PubMed ID: 24668948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System.
    Oh J; Kim JH; Park HD
    Ann Lab Med; 2018 Nov; 38(6):530-537. PubMed ID: 30027696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods.
    Bowsher RR; Nowatzke WL
    Bioanalysis; 2011 Apr; 3(8):883-98. PubMed ID: 21510762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits.
    Regester LE; Chmiel JD; Holler JM; Vorce SP; Levine B; Bosy TZ
    J Anal Toxicol; 2015 Mar; 39(2):144-51. PubMed ID: 25492523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antigen-antibody reaction using a fluorescent probe and its application to homogeneous competitive-type immunoassay for insulin.
    Oneda H; Inouye K
    Biosci Biotechnol Biochem; 2004 Oct; 68(10):2190-2. PubMed ID: 15502368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falsely high sirolimus concentrations due to everolimus cross-reactivity in the Siemens sirolimus immunoassay: Corrective actions implemented.
    Bowen R; Rieta R; Joshi R; Lee RC
    Clin Chim Acta; 2019 Feb; 489():162-163. PubMed ID: 29080689
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity.
    Brate EM; Finley DM; Grote J; Holets-McCormack S; Ozaeta PF; Pacenti D; Peart JE; Piktel RE; Ramsay CS; Rupprecht KR; Saldana SC; Spring TG; Tetin SY; Trudeau BC; Wang P; Xie H
    Clin Biochem; 2010 Sep; 43(13-14):1152-7. PubMed ID: 20599875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in cross-reactivity of novel insulin analogues in immunometric insulin assays.
    Krull I; Sahli R; Diem P; Stettler C
    Diabet Med; 2009 Oct; 26(10):1075-6. PubMed ID: 19900243
    [No Abstract]   [Full Text] [Related]  

  • 20. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.
    Rönnberg B; Gustafsson Å; Vapalahti O; Emmerich P; Lundkvist Å; Schmidt-Chanasit J; Blomberg J
    Med Microbiol Immunol; 2017 Oct; 206(5):383-401. PubMed ID: 28852878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.